Masimo is partnering with Qualcomm Technologies to develop a comprehensive reference platform to expand the Wear OS by Google™ ecosystem.

Masimo’s key technologies include the widely used Masimo SET pulse oximetry, which has improved outcomes in more than 200 million patients worldwide and is recognized by the top U.S. hospitals.

Masimo SET ® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry ...

Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing a summary of the core issues to consider in ...

Google's Wear OS will see health tracking upgrades courtesy of Masimo, the patent-holder responsible for blocking Apple Watch ...

Our mission is to improve life, improve patient outcomes, and reduce the cost of care. Masimo SET ® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over ...

You’ve reached your account maximum for followed topics. Courts blocked Apple from enabling blood oxygen sensors in the Apple Watch due to patent infringement on medical device company Masimo ...

Masimo Corporation MASI has announced a partnership with Qualcomm Technologies to create a next-generation smartwatch ...